Re: Fascelli et al: Combined biparametric prostate magnetic resonance ımaging and prostate-specific antigen in the detection of prostate cancer: A validation study in a biopsy-naive patient population (urology 2016; 88:125-134)
Yükleniyor...
Tarih
2016
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Elsevier Science Inc
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
I read with interest the article by Fascelli et al1The authorsaimed to validate the use of biparametric (T2- and diffusion-weighted) magnetic resonance imaging and prostate-specific antigen (PSA) or PSA density in a biopsy-naivecohort at risk for prostate cancer (PCa) and they used for-mulas for validation.
Açıklama
WOS: 000383698300057
PubMed ID: 27112511
PubMed ID: 27112511
Anahtar Kelimeler
Mortality, Biparametric, Prostate
Kaynak
Urology
WoS Q Değeri
Q3
Scopus Q Değeri
Q1
Cilt
95
Sayı
Künye
Sertkaya, Z. (2016). Re: Fascelli et al: Combined biparametric prostate magnetic resonance ımaging and prostate-specific antigen in the detection of prostate cancer: A validation study in a biopsy-naive patient population (urology 2016; 88:125-134). Urology, 95, 223-223. https://dx.doi.org/10.1016/j.urology.2016.04.011.
